Douglas F. Kling
2016
In 2016, Douglas F. Kling earned a total compensation of $398.5K as Senior Vice President, Clinical Development & Project Management at Matinas BioPharma Holdings, a 16% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $62,000 |
| Salary | $236,458 |
| Total | $398,458 |
Kling received $236.5K in salary, accounting for 59% of the total pay in 2016.
Kling also received $100K in bonus and $62K in option awards.
Rankings
In 2016, Douglas F. Kling's compensation ranked 11,936th out of 14,075 executives tracked by ExecPay. In other words, Kling earned more than 15.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,936 out of 14,075 | 15th |
Division Manufacturing | 4,680 out of 5,486 | 15th |
Major group Chemicals And Allied Products | 1,674 out of 1,900 | 12th |
Industry group Drugs | 1,359 out of 1,543 | 12th |
Industry Pharmaceutical Preparations | 1,048 out of 1,173 | 11th |
Source: SEC filing on September 14, 2017.
Kling's colleagues
We found two more compensation records of executives who worked with Douglas F. Kling at Matinas BioPharma Holdings in 2016.